Purchases and Sales Made in Q4 2024 in A Ikido Pharma Inc. (AIKI)
This table provides information about the institutional ownership of A Ikido Pharma Inc. (AIKI) during Q4 2024. The information is specifically focused on institutions that hold shares of AIkido Pharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
16.5KNew |
N/A
|
16.5K
$62.8K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
9.4K+ 20.03% |
N/A
|
56.3K
$214K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
4.66K+ 67.79% |
N/A
|
11.5K
$43.9K
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
379+ 9.99% |
N/A
|
4.17K
$15.8K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
278New |
N/A
|
278
$1.06K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-242- 0.56% |
N/A
|
43.1K
$164K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-1.5K- 7.32% |
N/A
|
19K
$72.2K
|